Kidney Stones And High Levels Of Calcium.
Some proletariat who come about recurring kidney stones may also have high levels of calcium deposits in their blood vessels, and that could clarify their increased risk for heart disease, new research suggests. "It's fitting clear that having kidney stones is a bit like having raised blood pressure, raised blood lipids such as cholesterol or diabetes in that it is another meter of, or risk factor for, cardiovascular cancer and its consequences," said study co-author Dr Robert Unwin, of University College London. Unwin is currently governor scientist with the AstraZeneca cardiovascular and metabolic diseases innovative medicines and initially development science unit, in Molndal, Sweden.
The main message: "is to begin to choose having kidney stones seriously in relation to cardiovascular disease risk, and to vocation preventive monitoring and treatments, including diet and lifestyle". Some 10 percent of men and 7 percent of women expand kidney stones at some point in their lives, and dig into has shown that many of these people are at heightened risk for high blood pressure, chronic kidney disease and sympathy disease, the researchers said.
But study author Dr Linda Shavit, a senior nephrologist at Shaare Zedek Medical Center in Jerusalem, and her colleagues wanted to declare out whether the heart issues that can take place in some of those with kidney stones might be caused by high levels of calcium deposits in their blood vessels. Using CT scans, they looked at calcium deposits in the abdominal aorta, one of the largest blood vessels in the body. Of the 111 tribe in the study, 57 suffered recurring kidney stones that were comprised of calcium (kidney stones can be made up of other minerals, depending on the patient's circumstances, the researchers noted), and 54 did not have kidney stones.
Showing posts with label calcium. Show all posts
Showing posts with label calcium. Show all posts
Thursday 23 May 2019
Saturday 5 January 2019
Calcium And Vitamin D Reduce The Risk Of Skin Tumors
Calcium And Vitamin D Reduce The Risk Of Skin Tumors.
Certain women at imperil for developing melanoma, the most life-threatening form of skin cancer, may hew down the likelihood in half by taking vitamin D with calcium supplements, a new study suggests. "It looks disposed to there is some promising evidence for vitamin D and calcium for prevention of melanoma in a high-risk group," said premier danseur researcher Dr Jean Tang, an assistant professor of dermatology at Stanford University School of Medicine.
The women most at endanger of developing the life-threatening cancer are those who have had a one-time non-melanoma form of skin cancer, such as basal cell or squamous cell cancer, the researchers said. Vitamin D and calcium are acknowledged for their roles in bone growth, but they also affect other cells in the body. Some studies have shown that vitamin D and calcium are associated with humiliate risk of colon, breast, prostate and other cancers, the researchers said.
Tang speculated that cancer cells lurking in the coating of women who have had a anterior skin cancer may be waiting to develop into melanoma. "But if they take calcium and vitamin D that reduces the danger of developing an actual tumor". As little as 400 worldwide units (IU) of vitamin D daily may be protective.
The US Institute of Medicine now recommends 600 IU of vitamin D daily. Calcium has also been shown to limit tumor swelling in patients with colon cancer. "So maybe calcium has a role, too. I can't aver whether it was the calcium or the vitamin D that was important". But the combination seemed to convey a benefit.
Whether these results would be seen in men or childish women isn't known. But an earlier study led by Tang found a profit from vitamin D in reducing the risk of melanoma among older men. "More studies for to be done, because we want to make sure these results are true in other communities".
The news was published in the June 27 2011 online edition of the Journal of Clinical Oncology. For the study, Tang's duo collected data on 36282 postmenopausal women, 50 to 79 years old, who took section in the Women's Health Initiative study.
Certain women at imperil for developing melanoma, the most life-threatening form of skin cancer, may hew down the likelihood in half by taking vitamin D with calcium supplements, a new study suggests. "It looks disposed to there is some promising evidence for vitamin D and calcium for prevention of melanoma in a high-risk group," said premier danseur researcher Dr Jean Tang, an assistant professor of dermatology at Stanford University School of Medicine.
The women most at endanger of developing the life-threatening cancer are those who have had a one-time non-melanoma form of skin cancer, such as basal cell or squamous cell cancer, the researchers said. Vitamin D and calcium are acknowledged for their roles in bone growth, but they also affect other cells in the body. Some studies have shown that vitamin D and calcium are associated with humiliate risk of colon, breast, prostate and other cancers, the researchers said.
Tang speculated that cancer cells lurking in the coating of women who have had a anterior skin cancer may be waiting to develop into melanoma. "But if they take calcium and vitamin D that reduces the danger of developing an actual tumor". As little as 400 worldwide units (IU) of vitamin D daily may be protective.
The US Institute of Medicine now recommends 600 IU of vitamin D daily. Calcium has also been shown to limit tumor swelling in patients with colon cancer. "So maybe calcium has a role, too. I can't aver whether it was the calcium or the vitamin D that was important". But the combination seemed to convey a benefit.
Whether these results would be seen in men or childish women isn't known. But an earlier study led by Tang found a profit from vitamin D in reducing the risk of melanoma among older men. "More studies for to be done, because we want to make sure these results are true in other communities".
The news was published in the June 27 2011 online edition of the Journal of Clinical Oncology. For the study, Tang's duo collected data on 36282 postmenopausal women, 50 to 79 years old, who took section in the Women's Health Initiative study.
Subscribe to:
Posts (Atom)